Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion

Armando Tripodi, Massimo Primignani, Veena Chantarangkul, Laura Lemma, Manol Jovani, Paolo Rebulla, Pier M. Mannucci

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Background/Aims: Cirrhosis presents with variable degrees of thrombocytopenia that might cause bleeding during invasive procedures. Transfusion of one standard adult platelet dose is often employed to prevent bleeding in thrombocytopenia, but the threshold platelet count that is clinically effective is not well established because clinical studies and laboratory tools to judge on efficacy are insufficient. However, in vitro studies showed that patients with cirrhosis generate as much thrombin as healthy individuals provided that their platelet count is at least 100 × 109/L. Methods: To assess the in vivo relevance of these in vitro studies, we investigated 26 thrombocytopenic patients with cirrhosis, undergoing 36 variceal ligations, to see whether transfusion of one standard adult platelet dose was able to attain the above platelet count. We also evaluated the effect of platelet transfusion on such global hemostasis tests as thrombin generation and thromboelastometry. Results: Transfusion did slightly increase platelet count [pre- vs. post-infusion: 39 × 109/L(16-64) vs. 52 × 109/L(19-91), P 9/L in all patients. In addition, the percentage of patients with abnormal thrombin generation (i.e. below the lower limit of normal range) was scarcely affected by transfusion (pre- vs. post-infusion: 36% vs. 42%). The small post-transfusion increase in platelet count was paralleled by some degree of improvement of thromboelastometry, but none of the patients reached normal values after transfusion. Conclusions: Infusing one standard adult platelet dose secures only a small increase in platelet count without normalizing thrombin generation and thromboelastometry tests. To obtain greater increases in platelet count and normalization of laboratory tests more intensive platelet transfusions or treatment with non-transfusional drugs are probably needed.

Original languageEnglish
Pages (from-to)362-367
Number of pages6
JournalLiver International
Volume33
Issue number3
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Platelet Transfusion
Hemostasis
Platelet Count
Fibrosis
Thrombelastography
Thrombin
Blood Platelets
Thrombocytopenia
Reference Values
Hemorrhage
Ligation
Pharmaceutical Preparations

Keywords

  • Haemorrhage
  • Thrombin generation
  • Thrombocytopenia
  • Thromboelastometry

ASJC Scopus subject areas

  • Hepatology

Cite this

Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion. / Tripodi, Armando; Primignani, Massimo; Chantarangkul, Veena; Lemma, Laura; Jovani, Manol; Rebulla, Paolo; Mannucci, Pier M.

In: Liver International, Vol. 33, No. 3, 03.2013, p. 362-367.

Research output: Contribution to journalArticle

@article{bb1483c35f6b447a82bc8bc18ff6e7ad,
title = "Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion",
abstract = "Background/Aims: Cirrhosis presents with variable degrees of thrombocytopenia that might cause bleeding during invasive procedures. Transfusion of one standard adult platelet dose is often employed to prevent bleeding in thrombocytopenia, but the threshold platelet count that is clinically effective is not well established because clinical studies and laboratory tools to judge on efficacy are insufficient. However, in vitro studies showed that patients with cirrhosis generate as much thrombin as healthy individuals provided that their platelet count is at least 100 × 109/L. Methods: To assess the in vivo relevance of these in vitro studies, we investigated 26 thrombocytopenic patients with cirrhosis, undergoing 36 variceal ligations, to see whether transfusion of one standard adult platelet dose was able to attain the above platelet count. We also evaluated the effect of platelet transfusion on such global hemostasis tests as thrombin generation and thromboelastometry. Results: Transfusion did slightly increase platelet count [pre- vs. post-infusion: 39 × 109/L(16-64) vs. 52 × 109/L(19-91), P 9/L in all patients. In addition, the percentage of patients with abnormal thrombin generation (i.e. below the lower limit of normal range) was scarcely affected by transfusion (pre- vs. post-infusion: 36{\%} vs. 42{\%}). The small post-transfusion increase in platelet count was paralleled by some degree of improvement of thromboelastometry, but none of the patients reached normal values after transfusion. Conclusions: Infusing one standard adult platelet dose secures only a small increase in platelet count without normalizing thrombin generation and thromboelastometry tests. To obtain greater increases in platelet count and normalization of laboratory tests more intensive platelet transfusions or treatment with non-transfusional drugs are probably needed.",
keywords = "Haemorrhage, Thrombin generation, Thrombocytopenia, Thromboelastometry",
author = "Armando Tripodi and Massimo Primignani and Veena Chantarangkul and Laura Lemma and Manol Jovani and Paolo Rebulla and Mannucci, {Pier M.}",
year = "2013",
month = "3",
doi = "10.1111/liv.12038",
language = "English",
volume = "33",
pages = "362--367",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "3",

}

TY - JOUR

T1 - Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion

AU - Tripodi, Armando

AU - Primignani, Massimo

AU - Chantarangkul, Veena

AU - Lemma, Laura

AU - Jovani, Manol

AU - Rebulla, Paolo

AU - Mannucci, Pier M.

PY - 2013/3

Y1 - 2013/3

N2 - Background/Aims: Cirrhosis presents with variable degrees of thrombocytopenia that might cause bleeding during invasive procedures. Transfusion of one standard adult platelet dose is often employed to prevent bleeding in thrombocytopenia, but the threshold platelet count that is clinically effective is not well established because clinical studies and laboratory tools to judge on efficacy are insufficient. However, in vitro studies showed that patients with cirrhosis generate as much thrombin as healthy individuals provided that their platelet count is at least 100 × 109/L. Methods: To assess the in vivo relevance of these in vitro studies, we investigated 26 thrombocytopenic patients with cirrhosis, undergoing 36 variceal ligations, to see whether transfusion of one standard adult platelet dose was able to attain the above platelet count. We also evaluated the effect of platelet transfusion on such global hemostasis tests as thrombin generation and thromboelastometry. Results: Transfusion did slightly increase platelet count [pre- vs. post-infusion: 39 × 109/L(16-64) vs. 52 × 109/L(19-91), P 9/L in all patients. In addition, the percentage of patients with abnormal thrombin generation (i.e. below the lower limit of normal range) was scarcely affected by transfusion (pre- vs. post-infusion: 36% vs. 42%). The small post-transfusion increase in platelet count was paralleled by some degree of improvement of thromboelastometry, but none of the patients reached normal values after transfusion. Conclusions: Infusing one standard adult platelet dose secures only a small increase in platelet count without normalizing thrombin generation and thromboelastometry tests. To obtain greater increases in platelet count and normalization of laboratory tests more intensive platelet transfusions or treatment with non-transfusional drugs are probably needed.

AB - Background/Aims: Cirrhosis presents with variable degrees of thrombocytopenia that might cause bleeding during invasive procedures. Transfusion of one standard adult platelet dose is often employed to prevent bleeding in thrombocytopenia, but the threshold platelet count that is clinically effective is not well established because clinical studies and laboratory tools to judge on efficacy are insufficient. However, in vitro studies showed that patients with cirrhosis generate as much thrombin as healthy individuals provided that their platelet count is at least 100 × 109/L. Methods: To assess the in vivo relevance of these in vitro studies, we investigated 26 thrombocytopenic patients with cirrhosis, undergoing 36 variceal ligations, to see whether transfusion of one standard adult platelet dose was able to attain the above platelet count. We also evaluated the effect of platelet transfusion on such global hemostasis tests as thrombin generation and thromboelastometry. Results: Transfusion did slightly increase platelet count [pre- vs. post-infusion: 39 × 109/L(16-64) vs. 52 × 109/L(19-91), P 9/L in all patients. In addition, the percentage of patients with abnormal thrombin generation (i.e. below the lower limit of normal range) was scarcely affected by transfusion (pre- vs. post-infusion: 36% vs. 42%). The small post-transfusion increase in platelet count was paralleled by some degree of improvement of thromboelastometry, but none of the patients reached normal values after transfusion. Conclusions: Infusing one standard adult platelet dose secures only a small increase in platelet count without normalizing thrombin generation and thromboelastometry tests. To obtain greater increases in platelet count and normalization of laboratory tests more intensive platelet transfusions or treatment with non-transfusional drugs are probably needed.

KW - Haemorrhage

KW - Thrombin generation

KW - Thrombocytopenia

KW - Thromboelastometry

UR - http://www.scopus.com/inward/record.url?scp=84873733438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873733438&partnerID=8YFLogxK

U2 - 10.1111/liv.12038

DO - 10.1111/liv.12038

M3 - Article

C2 - 23231699

AN - SCOPUS:84873733438

VL - 33

SP - 362

EP - 367

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 3

ER -